Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

13.82
-0.4236-2.97%
Post-market: 13.820.00000.00%16:10 EDT
Volume:16
Turnover:225
Market Cap:207.35K
PE:- -
High:13.82
Open:14.25
Low:13.82
Close:14.25
52wk High:27.19
52wk Low:13.82
Shares:15.00K
Float Shares:15.00K
Volume Ratio:0.12
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk A/S Series B Stock Falls Monday, Outperforms Market

Dow Jones
·
Sep 29

Taking Ozempic? a Routine Eye Exam Could Help You Understand Your Risk for Vision Loss

Dow Jones
·
Sep 28

ETF Weekly | QCML Soars 27%; INTW, AMUU, FBL, AMDL Jump 26%; SOXL Rallies 22%; Semiconductor Longs Lead

ETF Weekly
·
Sep 27

Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities

TIPRANKS
·
Sep 26

Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance

Deep News
·
Sep 25

After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring

Dow Jones
·
Sep 25

Novo Nordisk Licenses Nanexa Drug Delivery Technology

MT Newswires Live
·
Sep 25

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%

TIPRANKS
·
Sep 25

Novo Nordisk A/S Series B Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 25

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Novo Nordisk's new strategy hinges on something it cannot manufacture: investor confidence

Deep News
·
Sep 24

Morning Brief | October Hike Odds Near Seventy Percent As Nasdaq Falls Over One Percent; Cybersecurity Bucks The Trend, TSMC To Lift Prices Three To Six Percent Next Year

Options & Short Sell
·
Sep 24

Novo Nordisk A/S Stock (NVO) Closed Down by 3.12% on Sep 23: Key Drivers Unveiled

TradingKey
·
Sep 24

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Sep 24

Novo Nordisk says CagriSema delivers ‘superior’ weight loss in REIMAGINE 5 trial

TIPRANKS
·
Sep 23

Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments

MT Newswires Live
·
Sep 23

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Reuters
·
Sep 23

Market Chatter: Novo Nordisk Mulls Direct NYSE Listing to Boost US Profile

MT Newswires Live
·
Sep 23

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO) and Alcon (ALC)

TIPRANKS
·
Sep 23

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.89%

TIPRANKS
·
Sep 23